Figure Captions
Figure 1. Study design diagram
Figure 2. Least square means and corresponding standard error of dopamine (A), epinephrine (B), norepinephrine (C), normetanephrine (D), homovanillic acid (E), and vanillylmandelic acid (F) 24-hour urine excretion profiles
Figure 3. Percentage (arithmetic mean) of plasmatic inhibition of DβH activity at pre-dose (trough) following administration of zamicastat 400 mg (once daily) and placebo (PP-PD population, n=21). (DβH: dopamine-β-hydroxylase; PP-PD: per-protocol pharmacodynamics)